Parenteral nutrition-associated hyperglycemia in noncritically ill inpatients is associated with higher mortality
- PMID: 20652162
- PMCID: PMC2918487
- DOI: 10.1155/2010/718526
Parenteral nutrition-associated hyperglycemia in noncritically ill inpatients is associated with higher mortality
Abstract
Background: Hyperglycemia is a marker of poor clinical outcomes in studies evaluating hospitalized critically ill patients.
Objectives: To identify whether glycemic control is associated with health outcomes including acute coronary events, renal failure, infection, hospital length of stay, intensive care unit (ICU) admission, sepsis and mortality in noncritically ill patients administered parenteral nutrition (PN), and to compare the current standard of care for glucose monitoring at the Foothills Medical Centre (Calgary, Alberta) with the 2009 American Society of Parenteral and Enteral Nutrition guidelines.
Methods: A retrospective chart review of 100 adult (18 years of age or older) non-ICU inpatients who received PN for seven days or longer at the Foothills Medical Centre was conducted.
Results: Seventeen patients (17%) had a mean blood glucose level of 10.0 mmol/L or greater. PN patients with a mean blood glucose level of 10 mmol/L or greater had a higher rate of mortality than patients with a mean blood glucose level of less than 10 mmol/L (OR 7.22; 95% CI 1.08 to 48.29; P=0.042). Hyperglycemia was independently and significantly associated with mortality when adjusted for age and sex. Acute coronary events, renal failure, infection, hospital length of stay, ventilator use and ICU admissions were not associated with hyperglycemia. Only one-half of those with hyperglycemia, and none of the patients in the euglycemic group, received adequate glucose monitoring during the first two days of PN.
Conclusion: Hyperglycemia in noncritically ill inpatients receiving PN was found to be a risk factor for increased mortality.
HISTORIQUE :: L’hyperglycémie est un marqueur de mauvaises issues cliniques dans des études évaluant des patients hospitalisés gravement malades.
OBJECTIFS :: Déterminer si le contrôle de la glycémie s’associe à des issues de santé, y compris les événements coronariens aigus, l’insuffisance rénale, l’infection, la durée d’hospitalisation, l’admission aux soins intensifs (SI), la sepsie et la mortalité chez des patients sous alimentation parentérale (AP), et comparer la norme actuelle de surveillance de la glycémie au Foothills Medical Centre (de Calgary, en Alberta) avec les lignes directrices 2009 de l’American Society of Parenteral and Enteral Nutrition.
MÉTHODOLOGIE :: Les chercheurs ont procédé à l’examen rétrospectif du dossier de 100 patients hospitalisés (d’au moins 18 ans) qui n’étaient pas aux soins intensifs et qui ont été sous AP pendant au moins sept jours au Foothills Medical Centre.
RÉSULTATS :: Dix-sept patients (17 %) avaient une glycémie moyenne d’au moins 10,0 mmol/L. Les patients sous AP dont la glycémie moyenne était d’au moins 10 mmol/L présentaient un taux de mortalité plus élevé que ceux dont la glycémie était de 10 mmol/L ou moins (RRR 7,22; 95 % IC 1,08 à 48,29; P=0,042). L’hyperglycémie s’associait de manière indépendante et significative à la mortalité après rajustement compte tenu de l’âge et du sexe. Les événements coronariens aigus, l’insuffisance rénale, l’infection, la durée d’hospitalisation, le recours au respirateur et les admissions aux SI n’étaient pas liés à l’hyperglycémie. Seulement la moitié des patients hyperglycémiques, et aucun de ceux faisant partie du groupe euglycémique, ont reçu une surveillance pertinente de leur glycémie pendant les deux premiers jours d’AP.
CONCLUSION :: Les chercheurs ont déterminé que l’hyperglycémie était un facteur de risque de mortalité accrue chez les patients sous AP qui n’étaient pas gravement maladies
Figures




Similar articles
-
Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study.JPEN J Parenter Enteral Nutr. 2017 Sep;41(7):1110-1118. doi: 10.1177/0148607116644710. Epub 2016 Apr 18. JPEN J Parenter Enteral Nutr. 2017. PMID: 27091835 Clinical Trial.
-
Hyperglycemia is associated with increased hospital complications and mortality during parenteral nutrition.Hosp Pract (1995). 2011 Apr;39(2):81-8. doi: 10.3810/hp.2011.04.397. Hosp Pract (1995). 2011. PMID: 21576900
-
Hyperglycemia is associated with poor outcomes in surgical critically ill patients receiving parenteral nutrition.Acta Anaesthesiol Taiwan. 2013 Jun;51(2):67-72. doi: 10.1016/j.aat.2013.06.004. Epub 2013 Aug 12. Acta Anaesthesiol Taiwan. 2013. PMID: 23968657
-
Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: A systematic evaluation of randomised controlled trials.Clin Nutr ESPEN. 2017 Feb;17:75-85. doi: 10.1016/j.clnesp.2016.09.007. Epub 2016 Oct 27. Clin Nutr ESPEN. 2017. PMID: 28361751 Review.
-
THE MANAGEMENT OF HYPERGLYCEMIA IN NONCRITICALLY ILL HOSPITALIZED PATIENTS TREATED WITH CONTINUOUS ENTERAL OR PARENTERAL NUTRITION.Endocr Pract. 2018 Oct 2;24(10):900-906. doi: 10.4158/EP-2018-0150. Epub 2018 Jul 23. Endocr Pract. 2018. PMID: 30035626 Review.
Cited by
-
Management of hyperglycemia during enteral and parenteral nutrition therapy.Curr Diab Rep. 2013 Feb;13(1):155-62. doi: 10.1007/s11892-012-0335-y. Curr Diab Rep. 2013. PMID: 23065369 Free PMC article. Review.
-
Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy.Sci Rep. 2018 Apr 12;8(1):5888. doi: 10.1038/s41598-018-24275-5. Sci Rep. 2018. PMID: 29651052 Free PMC article. Clinical Trial.
-
The T allele of TCF7L2 rs7903146 is associated with decreased glucose tolerance after bed rest in healthy older adults.Sci Rep. 2022 Apr 27;12(1):6897. doi: 10.1038/s41598-022-10683-1. Sci Rep. 2022. PMID: 35477971 Free PMC article.
-
Intensive versus conventional insulin therapy in nondiabetic patients receiving parenteral nutrition after D2 gastrectomy for gastric cancer: a randomized controlled trial.J Gastrointest Surg. 2011 Nov;15(11):1961-8. doi: 10.1007/s11605-011-1654-z. Epub 2011 Sep 9. J Gastrointest Surg. 2011. PMID: 21904964 Clinical Trial.
-
Nutritional status and hyperglycemia in the peritransplant period: a review of associations with parenteral nutrition and clinical outcomes.Rev Bras Hematol Hemoter. 2017 Apr-Jun;39(2):155-162. doi: 10.1016/j.bjhh.2016.09.016. Epub 2017 Feb 21. Rev Bras Hematol Hemoter. 2017. PMID: 28577653 Free PMC article.
References
-
- van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67. - PubMed
-
- Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97. - PubMed
-
- Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–82. - PubMed
-
- Cheung NW, Napier B, Zaccaria C, Fletcher JP. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005;28:2367–71. - PubMed
-
- Lin LY, Lin HC, Lee PC, Ma WY, Lin HD. Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci. 2007;333:261–5. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical